Clinical Trials Directory

Trials / Terminated

TerminatedNCT02826473

Focused Cognitive Testing in Inpatients

Analysis of Clinical- and Cost-effectiveness of Focused Cognitive Testing in Elective Inpatients

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
150 (actual)
Sponsor
Luzerner Kantonsspital · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Not accepted

Summary

Neurocognitive Disorder (NCD) affects over 116'000 people in Switzerland and is frequently unrecognized and underdiagnosed. Because missed and delayed diagnosis are associated with an increased burden of disease health Service Research has prompted a discussion about diagnostic guidelines and screening programs. Some argue that screening for NCD in primary care is the optimal strategy to increase recognition rates; others consider test protocols implemented into hospital admission assessments as more justified. There is no distinct recommendation due to a lack of empirical data on the benefits and harms of cognitive testing yet. This trial strives to fill this gap and provide information about the benefits, harms and the economic case of routine cognitive testing for neurocognitive disorder in high risk elective inpatients, in Switzerland. The investigators hypothesize that, cognitive tested patients, compared with patients not cognitive tested, will have higher health-related quality of life at 12months; and lower medical health care costs at 18months.

Conditions

Interventions

TypeNameDescription
OTHERBRAINCHECKSubjects of the Intervention-Group will undergo a brief cognitive assessment, using the BRAINCHECK, during hospital admission assessments. Subjects with positive results will then be referred to a Memory Clinic undergoing subsequent interdisciplinary comprehensive diagnostic examinations. Patients with established diagnosis will be invited to counselling services of the Alzheimer Association (providing social counselling).

Timeline

Start date
2017-04-01
Primary completion
2019-05-01
Completion
2019-05-01
First posted
2016-07-11
Last updated
2019-12-12

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT02826473. Inclusion in this directory is not an endorsement.